Are you looking for more steady energy
Further investigations by Moody and Holst indicated that the peptide either was or constituted part of a proglucagon precursor because similar fragments could be found in the pancreas (Moody, Holst, Thim, Lindkaer, Jensen)
Treatments with DSIP and the DSIP-CBBBP fusion peptide significantly countered this reduction, showcasing their potential as therapeutic agents for modulating hedonistic behavior
A qualitative model of weight cycling
The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all
Future research may eventually develop genuine transdermal GLP-1 medications, but these would be prescription medications requiring regulatory approval, not the supplements currently being marketed